X-37
PrivateLast Round
Series A
Nov 14, 2019
Total Funding Raised
$14.5M
Company Overview
X-37 is a drug discovery and artificial intelligence & machine learning company that develops drugs for cancer, autoimmune diseases, and anticoagulation using AI technology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
X-37 Comparables
Compare X-37 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genesis Molecular AI | 85% | |
| Iambic Therapeutics | 82% | |
| Valo Health | 78% |
X-37 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 14, 2019 |
X-37 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCVC Bio | Series A |
| Hemi Ventures | Series A |
| Alpha Intelligence Capital | Series A |
X-37 Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about X-37's valuation, stock price, and market status.
Is X-37 a public or private company?
X-37 is a private company.
What is the current stock price of X-37?
X-37 is a private company with no public stock price. No recent secondary market data is available.
How much is X-37 worth (valuation)?
Valuation information for X-37 is not publicly available.
Can I buy X-37 stock?
X-37 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was X-37's last funding round?
X-37's most recent funding round was Series A on November 14, 2019.
Who are the main investors in X-37?
Key investors in X-37 include DCVC Bio.
Will X-37 IPO soon?
No public IPO plans have been announced for X-37.
How can I track X-37 secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor X-37's secondary market activity and sign up for updates.